SlideShare a Scribd company logo
Merck KGaA
Darmstadt, Germany
Steven Strubbe, Technical Leader, BioReliance® End-to-End
Solutions
Guillaume Plane, Marketing and Development Manager,
BioReliance® End-to-End Solutions
Tips and Tricks from a Biodevelopment Center
Tech Transfer and
Scale-Up
Bioreactor Protection with the Viresolve® Barrier Filter | 16 August 2018
The life science business of
Merck KGaA, Darmstadt, Germany
operates as MilliporeSigma
in the U.S. and Canada.
2
3 Managing process scaling and tech transfer
Process transfer is a cornerstone of manufacturing
Process Transfer
Process
development
lab
Pilot lab
Clinical
manufacturing
Commercial
manufacturing
(internal)
Commercial
manufacturing
(external)
4 Managing process scaling and tech transfer
Process transfer is regulatory defined
ICH Q10:
“The goal of technology transfer activities is to transfer product and
process knowledge between development and manufacturing, and
within or between manufacturing sites to achieve product
realization. This knowledge forms the basis for the manufacturing
process, control strategy, process validation approach, and ongoing
continual improvement.”
Process Transfer
 Transfers have to be performed in an organized, methodical manner, with appropriate documentation
 We will focus on the transfer of process parameters and process knowledge (data)
Ishikawa diagram
5 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
6 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
7 Managing process scaling and tech transfer
Process Transfer Methodology
Method
Successful
tech transfer
 Tech transfer protocol
 Gap analysis
 Acceptance criteria
 Process knowledge (documentation)
 Risk analysis
 Responsibilities and accountabilities
 Form tech transfer teams and governance structures,
 Define project charter with goals and timelines,
 Consolidate process knowledge into transferable documentation,
 Analyze gaps and risks,
 Execute the Tech Transfer: work the plan,
 Demonstrate technical success: Meet Acceptance criteria,
 Finalize transfer: documentation, support of regulatory activities, follow-up actions, lessons learned.
8 Managing process scaling and tech transfer
Process Transfer Key activities
9 Managing process scaling and tech transfer
Process Transfer Key activities
Project Charter
Set expectations and responsibilities between partners
Project charter must include:
 A well-defined team structure
 Sub-teams for different disciplines
 Connect counterparts
 Establish communication paths
 A well defined governance structure to address issues
 Clearly described roles and responsibilities
 Clearly established success criteria
10 Managing process scaling and tech transfer
Process Transfer Key activities
Timeline
Kick off
meeting
Team
set up
Regulatory
requirements,
Technical and
Quality Agreement
Planning,
Risk analysis
Kick off meeting: Scope, transfer timelines and team members are defined
Team members: At least a project manager, a technical leader and a tech transfer team
Communication plan: Deliverables
Team members with their respective responsibilities
Communication flow path
Meeting frequency
Tech transfer protocol: Equipment
Raw materials and consumables
Detailed process description including critical parameters
Analytical methods
Tech Transfer
Protocol,
Reference
material
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
A Process Description document with an overview of each step and key process parameters is required
 Information should be described in a site and scale independent manner
 Site-specific details from previous process installations should also be gathered as examples
For example:
 Buffers may have been prepared in batch or via in-line dilution
 Bioreactors may have been operated with different sparger configurations
Process Transfer Key activities
11 Managing process scaling and tech transfer
Consolidated Process Knowledge
Use an electronic file sharing system
for document hosting – not email
Process Transfer Key activities
12 Managing process scaling and tech transfer
Gap analysis
Gaps can be addressed by
changing equipment, procedures,
or the process.
Changes may require specific new
validation studies or may be
covered through the Process
Qualification validation.
Process Transfer Key activities
13 Managing process scaling and tech transfer
Quality Risk Management
Risks are inherent to
technology transfers
Identifying, assessing, and
mitigating - or - accepting
risks defines the project
work scope of a transfer
From ICH Q9, two primary principles
of quality risk management are:
 Evaluation of risk to quality should be based
on scientific knowledge and ultimately link to
protection of patients
 The level of effort, formality, and documentation of
The quality risk management process should be
commensurate with the level of risk
Process Transfer Key activities
14 Managing process scaling and tech transfer
Process “Q/q”ualification
It is a demonstration that the process is
performing correctly at the receiving unit.
It is important to have Pre-defined Success
Criteria: step yield, impurities, titer, etc.
Process Transfer Key activities
15 Managing process scaling and tech transfer
Process changes
 Some process changes are inevitable based on
major differences in facility, equipment, or
operational practices.
 Proper experiments must be performed to
determine acceptability of the change. Small-
scale models may be a good tool for examining
the effects of changes.
 Pre-defined success criteria are key to timely
progress and make decisions. Otherwise, how
do you know if the proposed change is
acceptable?
Ishikawa diagram
16 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
17 Managing process scaling and tech transfer
Process Transfer Methodology
Machine (Equipment)
Successful
tech transfer
 Scale down model
 Characteristics
 Modelization
 IQ/OQ/PQ
Systems characteristics have to be considered
 Mixing efficiency can vary: Impeller type, position, size/tank….
 Sparging efficiency can vary: Sparger size, sparger position, bubble size…
 Fluid movement and G/L interaction can vary: Baffles type, position, interactions
18 Managing process scaling and tech transfer
Equipment knowledge and modelization
3 L 50 L 200 L 2 000 L
Systems characteristics have to be considered
 Mass transfer modeling can help
KL.a: Volumetric mass transfer coefficient (s-1)
P/V: Power per unit volume (W.m-3)
Vs: Superficial gas velocity (m.s-1)
19 Managing process scaling and tech transfer
Equipment knowledge and modelization
Design-Expert® Software
Factor Coding: Actual
KLa (hr-1)
Design points above predicted value
Design points below predicted value
34.71
4.07
X1 = A: P/V
X2 = B: Vs
0.000145546
0.000291093
0.000436639
0.000582185
0.000727732
1
4.8
8.6
12.4
16.2
20
0
10
20
30
40
KLa(hr-1) A: P/V (W/m3)
B: Vs (m/s)
Systems characteristics have to be considered
20 Managing process scaling and tech transfer
Equipment knowledge and modelization
3 L 50 L 200 L 2 000 L
Design-Expert® Software
Factor Coding: Actual
KLa (hr -1)
Design points above predicted value
Design points below predicted value
22.17
1.88
X1 = A: P/V
X2 = B: Vs
0.00031
0.000568
0.000826
0.001084
0.001342
0.0016
1
4.8
8.6
12.4
16.2
20
0
5
10
15
20
25
KLa(hr-1)
A: P/V (W/M3)
B: Vs (m/s)
Design-Expert® Software
Factor Coding: Actual
KLa (hr-1)
Design points above predicted value
Design points below predicted value
34.71
4.07
X1 = A: P/V
X2 = B: Vs
0.000145546
0.000291093
0.000436639
0.000582185
0.000727732
1
4.8
8.6
12.4
16.2
20
0
10
20
30
40
KLa(hr-1)
A: P/V (W/m3)
B: Vs (m/s)
Design-Expert® Software
Factor Coding: Actual
KLa (hr-1)
Design points above predicted value
Design points below predicted value
29.63
1.91
X1 = A: P/V
X2 = B: Vs
9.17849E-005
0.00018357
0.000275355
0.000367139
0.000458924
1
4.8
8.6
12.4
16.2
20
0
5
10
15
20
25
30
KLa(hr-1)
A: P/V (W/m3)B: Vs (m/s)
-Expert® Software
Coding: Actual
-1)
gn points above predicted value
gn points below predicted value
P/V
Vs
2.26125E-005
3.95718E-005
5.65311E-005
7.34905E-005
9.04498E-005
1
4.8
8.6
12.4
16.2
20
2
3
4
5
6
7
8
9
KLa(hr-1)
A: P/V (W/m3)B: Vs (m/s)
Systems characteristics have to be considered
21 Managing process scaling and tech transfer
Equipment knowledge and modelization
3 L 50 L 200 L 2 000 L
Pug/V 10,40 10,48 10,42 10,70
Kla 5,12 5,14 5,16 5,17
From 3 L to 2,000 L:
 From Equipment knowledge to Tech transfer and scale-up of any CHO Cell line
22 Managing process scaling and tech transfer
Case study: CHO Cell line
0
10
20
30
40
0 2 4 6 8 10 12 14
VCD(x10^6
cells/mL)
VCD
CHO-M CHO-K1 CHO-S
Ishikawa diagram
23 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
24 Managing process scaling and tech transfer
Process Transfer Methodology
Material (Raw)
Successful
tech transfer
 Supplier qualification
 Supply chain
 Regulation
Raw material assessment
Type Name Formula CAS # Supplier Manufacturer Reference ID interne Statut Id
MP Potassium Dihydrogenophosphate KH2PO4 7778-77-0 Merck Emprove
Created if
sufficient
grade
OK
Type Name Quality system Capacity Status
MP Potassium Dihydrogenophosphate OK OK OK
Supplier assessment
Global status OK
Type Nom Storage Conditions EHS risk Batch traceability Use statut
MP Potassium Dihydrogenophosphate OK OK OK OK
Use assessment
Case study
In-tech transfer of a stainless steel process to single use
PROCESS FITTING
• Load: ≤ 30 g/L
• Mode: Bind/Elute
• 3 wash steps
• Buffer elution: Formic acid
• Elution cond : 8 mS/cm
• Elution volume 6-7 BV
• Load: ≤ 30 g/L
• Mode: Bind/Elute
• 2 wash steps
• Buffer elution: citric acid
• Elution cond : 3.5 mS/cm
• Elution volume < 2.5 BV
Protein A capture
EHS Ok
Case study
In-tech transfer of a stainless steel process to single use
PROCESS FITTING
Cation Exchange Chromatography
• Resin
• Load: ≤ 30 g/L
• Mode: Bind/Elute
• Buffer eq: Acetate + NaCL gradient
• Elution cond: 15-20 mS/cm
• Resin
• Load: 500 – 700 g/L
• Mode: overloading
• Buffer eq: Acetate (No NaCl)
• No elution
• Cond 3 mS/cm
Case study
In-tech transfer of a stainless steel process to single use
PROCESS FITTING
Anion Exchange Chromatography
• Membrane
• Load dilution: 3X
• Load: 400 g/m²
• Mode: Flowthrough
• Resin
• No dilution
• Load: 300 g/L
• Mode: Flowthrough
Ishikawa diagram
29 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
30 Managing process scaling and tech transfer
Process Transfer Methodology
Environment (Facility)
Successful
tech transfer
 Flows in and out
 Equipment limitation
 Storage (raw material, buffer, product)
 Supply (water, gas, etc.)
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
 Different equipment
 Different need of supply (No CIP)
 Different need of storage (Bags)
 Different flows in and out
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
3 4 5 6 7 8 9 10 11 12 13 14 15
Titer(g/L)
Production days
200L Mobius 500L stainless steel
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
0
20
40
60
80
100
K7153A
Lot RS10-004
K7153A
Lot N063813001
Abundance%
CEX-HPLC
Main peak Acidic peak Basic peak
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
0.0
20.0
40.0
60.0
80.0
100.0
G0F
Abundance(%)
Most frequent glycan of interest
Drug susbtance from a production with a 500L stainless steel bioreactor
Drug susbtance from a production with a 200L Mobius bioreactor
Ishikawa diagram
36 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
37 Managing process scaling and tech transfer
Process Transfer Methodology
Manpower
Successful
tech transfer
 Equipment training
 Process knowledge
 GMP training
38 Managing process scaling and tech transfer
Training
 Process training
1. Scale down the process
2. Train operators in a development lab
 Equipment training
1. Specificities of the receiving site have to be taken into account
2. Training should occur after gap analysis
 GMP training
1. Training of operators should be controlled by QA
2. Traceability is required
Ishikawa diagram
39 Managing process scaling and tech transfer
Process Transfer Methodology
Method Material (Raw) Manpower
Machine (Equipment) Environment (Facility) Measurement
Successful
tech transfer
Ishikawa diagram
40 Managing process scaling and tech transfer
Process Transfer Methodology
Measurement
Successful
tech transfer
 Method transfer
 Method validation
 Analytical transfer / Qualification
41 Managing process scaling and tech transfer
Measurement
 Process analytics should be transferred at first
 Scale-down model of the process may help save money, time and resources
 Qualification of reactants is key
42 Managing process scaling and tech transfer
Review process performance
• If there are issues to be corrected, assign actions and plan the work
• If failures occurred due to flaws in the methods of transfer, amend
transfer procedures for future executions
Support Regulatory activities
• Document preparation for submissions
• Respond to questions
• Preparation for inspections
Implement systems for ongoing technical support of manufacturing
Finalize Transfer
The vibrant M and BioReliance are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective
owners. Detailed information on trademarks is available via publicly accessible resources.
© 2018 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

More Related Content

What's hot

Analytical procedures life cycle management
Analytical procedures life cycle managementAnalytical procedures life cycle management
Analytical procedures life cycle management
Chandra Prakash Singh
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
MilliporeSigma
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Merck Life Sciences
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
KBI Biopharma
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
MilliporeSigma
 
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesPromises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Merck Life Sciences
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
Sagar Savale
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up	Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up
MilliporeSigma
 
Cell Therapy Manufacturing: Regulations and Facilities
Cell Therapy Manufacturing:  Regulations and FacilitiesCell Therapy Manufacturing:  Regulations and Facilities
Cell Therapy Manufacturing: Regulations and Facilitieswrtolbert
 
Who Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile PharmaceuticalsWho Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile Pharmaceuticals
GMP EDUCATION : Not for Profit Organization
 
Modernizing Quality Management
Modernizing Quality ManagementModernizing Quality Management
Modernizing Quality Management
Veeva Systems
 
A Lifecycle Approach to Process Validation
A Lifecycle Approach to Process ValidationA Lifecycle Approach to Process Validation
A Lifecycle Approach to Process Validation
Institute of Validation Technology
 
Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer 
Merck Life Sciences
 
Pharma Hand Book of GMP and Q.A
Pharma Hand Book of GMP and Q.APharma Hand Book of GMP and Q.A
Pharma Hand Book of GMP and Q.A
Kunal Roy
 
Commercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journeyCommercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journey
Merck Life Sciences
 
Process Validation Master Planning DMAIC Fusion
Process Validation Master Planning DMAIC FusionProcess Validation Master Planning DMAIC Fusion
Process Validation Master Planning DMAIC Fusion
GENEO
 
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable SystemsScale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
KBI Biopharma
 
Latest Updates in Biosafety Testing for Gene Therapy
Latest Updates in Biosafety Testing for Gene TherapyLatest Updates in Biosafety Testing for Gene Therapy
Latest Updates in Biosafety Testing for Gene Therapy
MilliporeSigma
 

What's hot (20)

Analytical procedures life cycle management
Analytical procedures life cycle managementAnalytical procedures life cycle management
Analytical procedures life cycle management
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
 
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesPromises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up	Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up
 
Cell Therapy Manufacturing: Regulations and Facilities
Cell Therapy Manufacturing:  Regulations and FacilitiesCell Therapy Manufacturing:  Regulations and Facilities
Cell Therapy Manufacturing: Regulations and Facilities
 
Managing risk in cleaning validation
Managing risk in cleaning validationManaging risk in cleaning validation
Managing risk in cleaning validation
 
Who Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile PharmaceuticalsWho Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile Pharmaceuticals
 
Modernizing Quality Management
Modernizing Quality ManagementModernizing Quality Management
Modernizing Quality Management
 
A Lifecycle Approach to Process Validation
A Lifecycle Approach to Process ValidationA Lifecycle Approach to Process Validation
A Lifecycle Approach to Process Validation
 
Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer 
 
Pharma Hand Book of GMP and Q.A
Pharma Hand Book of GMP and Q.APharma Hand Book of GMP and Q.A
Pharma Hand Book of GMP and Q.A
 
Commercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journeyCommercializing antibody-drug conjugates: a CMO’s journey
Commercializing antibody-drug conjugates: a CMO’s journey
 
Process Validation Master Planning DMAIC Fusion
Process Validation Master Planning DMAIC FusionProcess Validation Master Planning DMAIC Fusion
Process Validation Master Planning DMAIC Fusion
 
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable SystemsScale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
 
Latest Updates in Biosafety Testing for Gene Therapy
Latest Updates in Biosafety Testing for Gene TherapyLatest Updates in Biosafety Testing for Gene Therapy
Latest Updates in Biosafety Testing for Gene Therapy
 
Quality Facilities HVAC and Water Systems
Quality Facilities HVAC and Water SystemsQuality Facilities HVAC and Water Systems
Quality Facilities HVAC and Water Systems
 

Similar to Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center

Lean Vs Six Sigma.ppt
Lean Vs Six Sigma.pptLean Vs Six Sigma.ppt
Lean Vs Six Sigma.ppt
ssuser09851b1
 
Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)
Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)
Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)
AdaCore
 
Six sigma ajal
Six sigma ajalSix sigma ajal
Six sigma ajal
AJAL A J
 
Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...
Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...
Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...
PMI Pearl City Chapter
 
Bruce Shaver Operations 2011
Bruce Shaver   Operations 2011Bruce Shaver   Operations 2011
Bruce Shaver Operations 2011
tbshaver
 
Business Model Disruption - The Step-wise Transition to Remote Operations
Business Model Disruption - The Step-wise Transition to Remote OperationsBusiness Model Disruption - The Step-wise Transition to Remote Operations
Business Model Disruption - The Step-wise Transition to Remote Operations
Yokogawa1
 
Quality Management and Quality Standard
Quality Management and Quality StandardQuality Management and Quality Standard
Quality Management and Quality Standard
Murageppa-QA
 
Successfully Achieving And Delivering Results Through Rigorous Project Select...
Successfully Achieving And Delivering ResultsThrough Rigorous Project Select...Successfully Achieving And Delivering ResultsThrough Rigorous Project Select...
Successfully Achieving And Delivering Results Through Rigorous Project Select...shawncarner
 
Value stream mapping for DevOps
Value stream mapping for DevOpsValue stream mapping for DevOps
Value stream mapping for DevOps
Marc Hornbeek
 
Technology transfer in Pharmaceutical Industry.pptx
Technology transfer in Pharmaceutical Industry.pptxTechnology transfer in Pharmaceutical Industry.pptx
Technology transfer in Pharmaceutical Industry.pptx
Neeraj Kumar Rai
 
Javier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control Plan
Javier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control PlanJavier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control Plan
Javier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control Plan
J. García - Verdugo
 
The Completions Group Overview
The Completions Group OverviewThe Completions Group Overview
The Completions Group Overview
Sterling McLeod
 
The Completions Group Overview
The Completions Group OverviewThe Completions Group Overview
The Completions Group Overview
Russ Hrapinski
 
Innovative Engineering Workshop Npi 30march10
Innovative Engineering Workshop   Npi   30march10Innovative Engineering Workshop   Npi   30march10
Innovative Engineering Workshop Npi 30march10mccall1966
 
QM-007-Design for 6 sigma
QM-007-Design for 6 sigmaQM-007-Design for 6 sigma
QM-007-Design for 6 sigmahandbook
 
Measuring quality of developments in a large industrial software factory with...
Measuring quality of developments in a large industrial software factory with...Measuring quality of developments in a large industrial software factory with...
Measuring quality of developments in a large industrial software factory with...
SpagoWorld
 
OW2Con 2013 - Measuring quality of software developments with Spago4Q
OW2Con 2013 - Measuring quality of software developments with Spago4QOW2Con 2013 - Measuring quality of software developments with Spago4Q
OW2Con 2013 - Measuring quality of software developments with Spago4Q
SpagoWorld
 
A living story: measuring quality of developments in a large industrial softw...
A living story: measuring quality of developments in a large industrial softw...A living story: measuring quality of developments in a large industrial softw...
A living story: measuring quality of developments in a large industrial softw...
OW2
 

Similar to Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center (20)

Lean Vs Six Sigma.ppt
Lean Vs Six Sigma.pptLean Vs Six Sigma.ppt
Lean Vs Six Sigma.ppt
 
Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)
Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)
Lean Thinking Inside and Outside a Software Engineering Company (Dave Jackson)
 
Six sigma ajal
Six sigma ajalSix sigma ajal
Six sigma ajal
 
Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...
Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...
Dhaval Shah on "Strategic Alignment Of Projects For Higher Profits And Increa...
 
Bruce Shaver Operations 2011
Bruce Shaver   Operations 2011Bruce Shaver   Operations 2011
Bruce Shaver Operations 2011
 
Harvinder Singh-Resume
Harvinder Singh-ResumeHarvinder Singh-Resume
Harvinder Singh-Resume
 
Business Model Disruption - The Step-wise Transition to Remote Operations
Business Model Disruption - The Step-wise Transition to Remote OperationsBusiness Model Disruption - The Step-wise Transition to Remote Operations
Business Model Disruption - The Step-wise Transition to Remote Operations
 
Quality Management and Quality Standard
Quality Management and Quality StandardQuality Management and Quality Standard
Quality Management and Quality Standard
 
Successfully Achieving And Delivering Results Through Rigorous Project Select...
Successfully Achieving And Delivering ResultsThrough Rigorous Project Select...Successfully Achieving And Delivering ResultsThrough Rigorous Project Select...
Successfully Achieving And Delivering Results Through Rigorous Project Select...
 
Value stream mapping for DevOps
Value stream mapping for DevOpsValue stream mapping for DevOps
Value stream mapping for DevOps
 
Technology transfer in Pharmaceutical Industry.pptx
Technology transfer in Pharmaceutical Industry.pptxTechnology transfer in Pharmaceutical Industry.pptx
Technology transfer in Pharmaceutical Industry.pptx
 
Javier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control Plan
Javier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control PlanJavier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control Plan
Javier Garcia - Verdugo Sanchez - Six Sigma Training - W2 Control Plan
 
The Completions Group Overview
The Completions Group OverviewThe Completions Group Overview
The Completions Group Overview
 
The Completions Group Overview
The Completions Group OverviewThe Completions Group Overview
The Completions Group Overview
 
Innovative Engineering Workshop Npi 30march10
Innovative Engineering Workshop   Npi   30march10Innovative Engineering Workshop   Npi   30march10
Innovative Engineering Workshop Npi 30march10
 
QM-007-Design for 6 sigma
QM-007-Design for 6 sigmaQM-007-Design for 6 sigma
QM-007-Design for 6 sigma
 
Measuring quality of developments in a large industrial software factory with...
Measuring quality of developments in a large industrial software factory with...Measuring quality of developments in a large industrial software factory with...
Measuring quality of developments in a large industrial software factory with...
 
OW2Con 2013 - Measuring quality of software developments with Spago4Q
OW2Con 2013 - Measuring quality of software developments with Spago4QOW2Con 2013 - Measuring quality of software developments with Spago4Q
OW2Con 2013 - Measuring quality of software developments with Spago4Q
 
Bhattacharyya_Keya-Elec.Eng
Bhattacharyya_Keya-Elec.EngBhattacharyya_Keya-Elec.Eng
Bhattacharyya_Keya-Elec.Eng
 
A living story: measuring quality of developments in a large industrial softw...
A living story: measuring quality of developments in a large industrial softw...A living story: measuring quality of developments in a large industrial softw...
A living story: measuring quality of developments in a large industrial softw...
 

More from MilliporeSigma

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
MilliporeSigma
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
MilliporeSigma
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
MilliporeSigma
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
MilliporeSigma
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
MilliporeSigma
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
MilliporeSigma
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
MilliporeSigma
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
MilliporeSigma
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
MilliporeSigma
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
MilliporeSigma
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
MilliporeSigma
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
MilliporeSigma
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?
MilliporeSigma
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
MilliporeSigma
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
MilliporeSigma
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
MilliporeSigma
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
MilliporeSigma
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
MilliporeSigma
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
MilliporeSigma
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
MilliporeSigma
 

More from MilliporeSigma (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
ranishasharma67
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
PGIMS Rohtak
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
preciousstephanie75
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
roti bank
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 

Recently uploaded (20)

GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 

Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center

  • 1. Merck KGaA Darmstadt, Germany Steven Strubbe, Technical Leader, BioReliance® End-to-End Solutions Guillaume Plane, Marketing and Development Manager, BioReliance® End-to-End Solutions Tips and Tricks from a Biodevelopment Center Tech Transfer and Scale-Up
  • 2. Bioreactor Protection with the Viresolve® Barrier Filter | 16 August 2018 The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. 2
  • 3. 3 Managing process scaling and tech transfer Process transfer is a cornerstone of manufacturing Process Transfer Process development lab Pilot lab Clinical manufacturing Commercial manufacturing (internal) Commercial manufacturing (external)
  • 4. 4 Managing process scaling and tech transfer Process transfer is regulatory defined ICH Q10: “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement.” Process Transfer  Transfers have to be performed in an organized, methodical manner, with appropriate documentation  We will focus on the transfer of process parameters and process knowledge (data)
  • 5. Ishikawa diagram 5 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 6. Ishikawa diagram 6 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 7. Ishikawa diagram 7 Managing process scaling and tech transfer Process Transfer Methodology Method Successful tech transfer  Tech transfer protocol  Gap analysis  Acceptance criteria  Process knowledge (documentation)  Risk analysis  Responsibilities and accountabilities
  • 8.  Form tech transfer teams and governance structures,  Define project charter with goals and timelines,  Consolidate process knowledge into transferable documentation,  Analyze gaps and risks,  Execute the Tech Transfer: work the plan,  Demonstrate technical success: Meet Acceptance criteria,  Finalize transfer: documentation, support of regulatory activities, follow-up actions, lessons learned. 8 Managing process scaling and tech transfer Process Transfer Key activities
  • 9. 9 Managing process scaling and tech transfer Process Transfer Key activities Project Charter Set expectations and responsibilities between partners Project charter must include:  A well-defined team structure  Sub-teams for different disciplines  Connect counterparts  Establish communication paths  A well defined governance structure to address issues  Clearly described roles and responsibilities  Clearly established success criteria
  • 10. 10 Managing process scaling and tech transfer Process Transfer Key activities Timeline Kick off meeting Team set up Regulatory requirements, Technical and Quality Agreement Planning, Risk analysis Kick off meeting: Scope, transfer timelines and team members are defined Team members: At least a project manager, a technical leader and a tech transfer team Communication plan: Deliverables Team members with their respective responsibilities Communication flow path Meeting frequency Tech transfer protocol: Equipment Raw materials and consumables Detailed process description including critical parameters Analytical methods Tech Transfer Protocol, Reference material Tech Transfer report Tech Transfer Closure Experiments
  • 11. A Process Description document with an overview of each step and key process parameters is required  Information should be described in a site and scale independent manner  Site-specific details from previous process installations should also be gathered as examples For example:  Buffers may have been prepared in batch or via in-line dilution  Bioreactors may have been operated with different sparger configurations Process Transfer Key activities 11 Managing process scaling and tech transfer Consolidated Process Knowledge Use an electronic file sharing system for document hosting – not email
  • 12. Process Transfer Key activities 12 Managing process scaling and tech transfer Gap analysis Gaps can be addressed by changing equipment, procedures, or the process. Changes may require specific new validation studies or may be covered through the Process Qualification validation.
  • 13. Process Transfer Key activities 13 Managing process scaling and tech transfer Quality Risk Management Risks are inherent to technology transfers Identifying, assessing, and mitigating - or - accepting risks defines the project work scope of a transfer From ICH Q9, two primary principles of quality risk management are:  Evaluation of risk to quality should be based on scientific knowledge and ultimately link to protection of patients  The level of effort, formality, and documentation of The quality risk management process should be commensurate with the level of risk
  • 14. Process Transfer Key activities 14 Managing process scaling and tech transfer Process “Q/q”ualification It is a demonstration that the process is performing correctly at the receiving unit. It is important to have Pre-defined Success Criteria: step yield, impurities, titer, etc.
  • 15. Process Transfer Key activities 15 Managing process scaling and tech transfer Process changes  Some process changes are inevitable based on major differences in facility, equipment, or operational practices.  Proper experiments must be performed to determine acceptability of the change. Small- scale models may be a good tool for examining the effects of changes.  Pre-defined success criteria are key to timely progress and make decisions. Otherwise, how do you know if the proposed change is acceptable?
  • 16. Ishikawa diagram 16 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 17. Ishikawa diagram 17 Managing process scaling and tech transfer Process Transfer Methodology Machine (Equipment) Successful tech transfer  Scale down model  Characteristics  Modelization  IQ/OQ/PQ
  • 18. Systems characteristics have to be considered  Mixing efficiency can vary: Impeller type, position, size/tank….  Sparging efficiency can vary: Sparger size, sparger position, bubble size…  Fluid movement and G/L interaction can vary: Baffles type, position, interactions 18 Managing process scaling and tech transfer Equipment knowledge and modelization 3 L 50 L 200 L 2 000 L
  • 19. Systems characteristics have to be considered  Mass transfer modeling can help KL.a: Volumetric mass transfer coefficient (s-1) P/V: Power per unit volume (W.m-3) Vs: Superficial gas velocity (m.s-1) 19 Managing process scaling and tech transfer Equipment knowledge and modelization Design-Expert® Software Factor Coding: Actual KLa (hr-1) Design points above predicted value Design points below predicted value 34.71 4.07 X1 = A: P/V X2 = B: Vs 0.000145546 0.000291093 0.000436639 0.000582185 0.000727732 1 4.8 8.6 12.4 16.2 20 0 10 20 30 40 KLa(hr-1) A: P/V (W/m3) B: Vs (m/s)
  • 20. Systems characteristics have to be considered 20 Managing process scaling and tech transfer Equipment knowledge and modelization 3 L 50 L 200 L 2 000 L Design-Expert® Software Factor Coding: Actual KLa (hr -1) Design points above predicted value Design points below predicted value 22.17 1.88 X1 = A: P/V X2 = B: Vs 0.00031 0.000568 0.000826 0.001084 0.001342 0.0016 1 4.8 8.6 12.4 16.2 20 0 5 10 15 20 25 KLa(hr-1) A: P/V (W/M3) B: Vs (m/s) Design-Expert® Software Factor Coding: Actual KLa (hr-1) Design points above predicted value Design points below predicted value 34.71 4.07 X1 = A: P/V X2 = B: Vs 0.000145546 0.000291093 0.000436639 0.000582185 0.000727732 1 4.8 8.6 12.4 16.2 20 0 10 20 30 40 KLa(hr-1) A: P/V (W/m3) B: Vs (m/s) Design-Expert® Software Factor Coding: Actual KLa (hr-1) Design points above predicted value Design points below predicted value 29.63 1.91 X1 = A: P/V X2 = B: Vs 9.17849E-005 0.00018357 0.000275355 0.000367139 0.000458924 1 4.8 8.6 12.4 16.2 20 0 5 10 15 20 25 30 KLa(hr-1) A: P/V (W/m3)B: Vs (m/s) -Expert® Software Coding: Actual -1) gn points above predicted value gn points below predicted value P/V Vs 2.26125E-005 3.95718E-005 5.65311E-005 7.34905E-005 9.04498E-005 1 4.8 8.6 12.4 16.2 20 2 3 4 5 6 7 8 9 KLa(hr-1) A: P/V (W/m3)B: Vs (m/s)
  • 21. Systems characteristics have to be considered 21 Managing process scaling and tech transfer Equipment knowledge and modelization 3 L 50 L 200 L 2 000 L Pug/V 10,40 10,48 10,42 10,70 Kla 5,12 5,14 5,16 5,17
  • 22. From 3 L to 2,000 L:  From Equipment knowledge to Tech transfer and scale-up of any CHO Cell line 22 Managing process scaling and tech transfer Case study: CHO Cell line 0 10 20 30 40 0 2 4 6 8 10 12 14 VCD(x10^6 cells/mL) VCD CHO-M CHO-K1 CHO-S
  • 23. Ishikawa diagram 23 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 24. Ishikawa diagram 24 Managing process scaling and tech transfer Process Transfer Methodology Material (Raw) Successful tech transfer  Supplier qualification  Supply chain  Regulation
  • 25. Raw material assessment Type Name Formula CAS # Supplier Manufacturer Reference ID interne Statut Id MP Potassium Dihydrogenophosphate KH2PO4 7778-77-0 Merck Emprove Created if sufficient grade OK Type Name Quality system Capacity Status MP Potassium Dihydrogenophosphate OK OK OK Supplier assessment Global status OK Type Nom Storage Conditions EHS risk Batch traceability Use statut MP Potassium Dihydrogenophosphate OK OK OK OK Use assessment
  • 26. Case study In-tech transfer of a stainless steel process to single use PROCESS FITTING • Load: ≤ 30 g/L • Mode: Bind/Elute • 3 wash steps • Buffer elution: Formic acid • Elution cond : 8 mS/cm • Elution volume 6-7 BV • Load: ≤ 30 g/L • Mode: Bind/Elute • 2 wash steps • Buffer elution: citric acid • Elution cond : 3.5 mS/cm • Elution volume < 2.5 BV Protein A capture EHS Ok
  • 27. Case study In-tech transfer of a stainless steel process to single use PROCESS FITTING Cation Exchange Chromatography • Resin • Load: ≤ 30 g/L • Mode: Bind/Elute • Buffer eq: Acetate + NaCL gradient • Elution cond: 15-20 mS/cm • Resin • Load: 500 – 700 g/L • Mode: overloading • Buffer eq: Acetate (No NaCl) • No elution • Cond 3 mS/cm
  • 28. Case study In-tech transfer of a stainless steel process to single use PROCESS FITTING Anion Exchange Chromatography • Membrane • Load dilution: 3X • Load: 400 g/m² • Mode: Flowthrough • Resin • No dilution • Load: 300 g/L • Mode: Flowthrough
  • 29. Ishikawa diagram 29 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 30. Ishikawa diagram 30 Managing process scaling and tech transfer Process Transfer Methodology Environment (Facility) Successful tech transfer  Flows in and out  Equipment limitation  Storage (raw material, buffer, product)  Supply (water, gas, etc.)
  • 31. Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments
  • 32. Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments  Different equipment  Different need of supply (No CIP)  Different need of storage (Bags)  Different flows in and out
  • 33. Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments 3 4 5 6 7 8 9 10 11 12 13 14 15 Titer(g/L) Production days 200L Mobius 500L stainless steel
  • 34. Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments 0 20 40 60 80 100 K7153A Lot RS10-004 K7153A Lot N063813001 Abundance% CEX-HPLC Main peak Acidic peak Basic peak
  • 35. Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments 0.0 20.0 40.0 60.0 80.0 100.0 G0F Abundance(%) Most frequent glycan of interest Drug susbtance from a production with a 500L stainless steel bioreactor Drug susbtance from a production with a 200L Mobius bioreactor
  • 36. Ishikawa diagram 36 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 37. Ishikawa diagram 37 Managing process scaling and tech transfer Process Transfer Methodology Manpower Successful tech transfer  Equipment training  Process knowledge  GMP training
  • 38. 38 Managing process scaling and tech transfer Training  Process training 1. Scale down the process 2. Train operators in a development lab  Equipment training 1. Specificities of the receiving site have to be taken into account 2. Training should occur after gap analysis  GMP training 1. Training of operators should be controlled by QA 2. Traceability is required
  • 39. Ishikawa diagram 39 Managing process scaling and tech transfer Process Transfer Methodology Method Material (Raw) Manpower Machine (Equipment) Environment (Facility) Measurement Successful tech transfer
  • 40. Ishikawa diagram 40 Managing process scaling and tech transfer Process Transfer Methodology Measurement Successful tech transfer  Method transfer  Method validation  Analytical transfer / Qualification
  • 41. 41 Managing process scaling and tech transfer Measurement  Process analytics should be transferred at first  Scale-down model of the process may help save money, time and resources  Qualification of reactants is key
  • 42. 42 Managing process scaling and tech transfer Review process performance • If there are issues to be corrected, assign actions and plan the work • If failures occurred due to flaws in the methods of transfer, amend transfer procedures for future executions Support Regulatory activities • Document preparation for submissions • Respond to questions • Preparation for inspections Implement systems for ongoing technical support of manufacturing Finalize Transfer
  • 43. The vibrant M and BioReliance are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. © 2018 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.